Amiodarone-Darnitsa

Preventing recurrence of: – Life-threatening ventricular tachycardia (Amiodarone-Darnitsa can only be administered in a hospital setting under observation) – Documented symptomatic and disabling ventricular tachycardia – Documented supraventricular tachycardia, if the need to prescribe the drug is established in patients with a condition that is resistant to other therapies or with contraindications to other methods of treating ventricular fibrillation Treatment of supraventricular tachycardia: slowing or reducing atrial fibrillation or flutter. Amiodarone can be used in patients with ischemic heart disease and/or left ventricular dysfunction (see the Pharmacodynamics Section).